Header Logo

Connection

Navin Varadarajan to Neoplasms

This is a "connection" page, showing publications Navin Varadarajan has written about Neoplasms.
Connection Strength

2.031
  1. Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition. Cell Death Dis. 2024 02 02; 15(2):109.
    View in: PubMed
    Score: 0.785
  2. Unmassked: Single-Cell Profiling of Immune Cell Populations in Tumors. Mol Ther. 2017 08 02; 25(8):1745-1747.
    View in: PubMed
    Score: 0.497
  3. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025 Jan; 637(8047):940-946.
    View in: PubMed
    Score: 0.208
  4. Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
    View in: PubMed
    Score: 0.159
  5. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8a?-engineered human CD4+ T cells. Sci Adv. 2020 07; 6(27):eaaz7809.
    View in: PubMed
    Score: 0.153
  6. IgG Fc domains that bind C1q but not effector Fc? receptors delineate the importance of complement-mediated effector functions. Nat Immunol. 2017 Aug; 18(8):889-898.
    View in: PubMed
    Score: 0.124
  7. Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells. Cancer Immunol Res. 2015 May; 3(5):473-82.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.